| Vertex Pharmaceuticals (CH) GmbH - Orkambi 150 mg lumacaftor / 188 mg ivacaftor, Granulat |
| 67395 | | 02 | | Orkambi 150 mg lumacaftor / 188 mg ivacaftor | | Granulat | | R07AX30 | | Ivacaftor and Lumacaftor | | 23.12.2019 | | |
|
| Composition |
| lumacaftorum 150 mg, ivacaftorum 188 mg, hypromellosi acetas succinas, natrii laurilsulfas, carmellosum natricum conexum, cellulosum microcristallinum, povidonum K 30 ad granulatum pro charta corresp. natrium max. 1.34 mg. |
| Packungsbestandteile |
| Granulate | | | | | | | | Active Agent | Dose |
|---|
| Ivacaftorum | 188 mg | | Lumacaftorum | 150 mg |
| | BAG: Active Agent | Dose |
|---|
| Ivacaftorum | 188 mg | | Lumacaftorum | 150 mg |
| | | | Inactive agents | Dose |
|---|
| Ad Granulatum | | | Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | Hypromellosi Acetas Succinas | | | Natrii Laurilsulfas | | | Povidonum K | 30 |
| |
|
|
